
Progenity, Inc. PROG
Progenity, Inc. DIO Ratio 2011-2026 | PROG
Annual DIO Ratio Progenity, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 47.7 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.7 | 47.7 | 47.7 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
BioCardia
BCDA
|
4.08 | $ 1.28 | 0.55 % | $ 27.1 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Catalyst Biosciences
CBIO
|
201 | $ 11.32 | -2.25 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
247 | $ 14.64 | 1.92 % | $ 215 M | ||
|
AVEO Pharmaceuticals
AVEO
|
63.8 | - | - | $ 521 M | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.64 | - | $ 16.6 M |